- Home
- PCVX vs EHC Comparison
PCVX vs EHC Comparison
Compare PCVX & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | EHC |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 10.1B |
| IPO Year | 2020 | 1986 |
Fundamental Metrics
Financial Performance| Metric | PCVX | EHC |
|---|---|---|
| Price | $53.36 | $98.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $105.00 | ★ $142.86 |
| AVG Volume (30 Days) | 1.0M | ★ 1.0M |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | N/A | ★ 27.89 |
| EPS | N/A | ★ 5.29 |
| Revenue | N/A | ★ $5,795,600,000.00 |
| Revenue This Year | N/A | $11.54 |
| Revenue Next Year | N/A | $8.76 |
| P/E Ratio | ★ N/A | $18.79 |
| Revenue Growth | N/A | ★ 11.13 |
| 52 Week Low | $27.66 | $92.53 |
| 52 Week High | $93.77 | $127.99 |
Technical Indicators
Market Signals| Indicator | PCVX | EHC |
|---|---|---|
| Relative Strength Index (RSI) | 68.26 | 28.52 |
| Support Level | $44.85 | $98.66 |
| Resistance Level | $48.93 | $100.42 |
| Average True Range (ATR) | 2.67 | 2.20 |
| MACD | 0.75 | -0.29 |
| Stochastic Oscillator | 76.40 | 7.91 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.